AbbVie's first DTC ads for age-related vision med Vuity highlight the 'wow' factor in the first-to-market eye drops.
March 21, 2022 01:09 PM EDTUpdated March 22, 11:12 AM
Pharma
Marketing

'Wait, what?' First TV ad for Ab­b­Vie’s Vuity pres­by­opia eye drops high­lights com­mon sur­prised re­ac­tion

Beth Snyder Bulik

Senior Editor

Ab­b­Vie’s first TV com­mer­cial for Vuity eye drops for age-re­lat­ed vi­sion loss stops sur­prised peo­ple in their tracks.

“Wait, what?” the mid­dle-aged, eye­glass-wear­ing ac­tors say …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

You bet your life: Af­ter I was di­ag­nosed with a rare can­cer, I dis­cov­ered how a small band of physi­cian-sci­en­tists ...

Biotech VC firm out­lines plans for $100M fund

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

No­vo says its CB1 drug helped shed weight, but ef­fi­ca­cy and safe­ty ques­tions re­main

FTC to sue ma­jor PBMs over in­sulin re­bates, claim­ing they in­flat­ed pa­tient cost

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times